Skip to main content
Caplight Logo









Chemify

Chemify

Private
Glasgow, ScotlandHealthcare & Life Scienceshttps://chemify.io

Last Round

Series B

Oct 21, 2025

Total Funding Raised

$93M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Chemify operates in Healthcare & Life Sciences and is based in Glasgow, Scotland. Its latest recorded funding round was a Series B round in October 2025.

Chemify is a chemical technology company that offers a digital platform for executing chemical code to facilitate drug and materials discovery as well as chemical synthesis.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Industrial Robotics, Advanced Materials, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Chemify Comparables

Compare Chemify with similar companies based on industry and business-model similarity.

Chemify comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Warp Sciences
82%
Satomic
79%
ChemLex
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Chemify Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 21, 2025
Series AAug 2, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Lee Cronin

CEO-Founder

Founding Team

Martin Stephenson

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

Chemify Investors

Notable investors and investment history

Chemify investors
InvestorRounds
Horizons VenturesSeries A
RockspringSeries B
BlueYard CapitalSeries B, Series A
Triatomic CapitalSeries B, Series A
Alix VenturesSeries A
Wing Venture CapitalSeries B
Possible VenturesSeries A
Book a demo to see all 10 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    A new manufacturing facility has opened in Glasgow.

  • Oct 21, 2025

    $50M Series B round completed.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingSep 16, 2026

    On Sep 22nd '26, Chemify, Ltd. receives a $69.5M Series B financing extension in Scotland, alongside £22 million in grants from Scottish Enterprise and the UK Government to expand its Chemifarm capacity.

  • expands_offices_toSep 16, 2026

    In Glasgow, Chemify, Ltd. plans to establish a new global headquarters and research and development centre, creating up to 300 jobs and increasing its Scottish workforce to around 450 over the next three years, as announced on Sep 16th '26.

  • expands_offices_toSep 16, 2026

    Chemify, Ltd. establishes its global headquarters and research and development centre at the University of Glasgow’s Health Innovation Hub in Govan as part of its expansion project.

  • expands_offices_inSep 16, 2026

    In Sep '26, Chemify, Ltd. plans to establish a global headquarters and research and development centre and expand its automated manufacturing operations in Glasgow, increasing its Scottish workforce from 152 to around 450 over the next three years and creating up to 300 jobs.

  • expands_facilitiesSep 16, 2026

    In Sep '26, Chemify, Ltd. plans to expand its next-generation Chemifarm in Glasgow with additional funding, increasing capacity and the Scottish workforce from 152 employees to around 450 over the next three years, creating up to 300 jobs and safeguarding a further 100 jobs.

Book a demo to see all news

For institutional investors. Book with your work email.

Chemify Filings

Explore SEC and related filing metadata, where available.

Chemify filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Chemify's valuation, stock price, and market status.

Is Chemify a public or private company?

Chemify is a private company.

What is the current stock price of Chemify?

Chemify is a private company, so its shares have no public market price. Caplight tracks Chemify's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Chemify worth (valuation)?

Valuation information for Chemify is not publicly available.

Can I buy Chemify stock?

Chemify shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Chemify's last funding round?

Chemify's most recent funding round was Series B on October 21, 2025.

Who are the main investors in Chemify?

Key investors in Chemify include Triatomic Capital, Wing Venture Capital, Insight Partners.

Will Chemify IPO soon?

No public IPO plans have been announced for Chemify.

How can I track Chemify secondary market activity?

Caplight tracks bids, offers, and trades in Chemify's shares on secondary markets.

Firmographic Details

HeadquartersGlasgow, Scotland
Employee Range155
Year Founded2019
Last FundingOct 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?